Helyx Industries is pleased to announce its inclusion in the new Operational Manual published by GISCi (Italian Group for Cervical Cancer Screening), focusing on the use of vaginal self-sampling for HR-HPV testing.

Helyx Industries is pleased to announce its inclusion in the new Operational Manual published by GISCi (Italian Group for Cervical Cancer Screening), focusing on the use of vaginal self-sampling for HR-HPV testing.

The Impact of Self-Sampling

The implementation of self-sampling marks a strategic turning point for public health: this method helps overcome barriers to access and significantly increases participation in organized screening programs. Scientific validation of the systems used is a fundamental requirement to ensure the same sensitivity and specificity as traditional clinician-collected samples.

Our Commitment

Since our founding, Helyx Industries’ mission has been to support diagnostic innovation through standards of excellence. Being featured among the validated technological systems by GISCi confirms the reliability of our solutions and our active role in strengthening the national oncological prevention network.

For further details and to review the recommendations on screening solutions, the official manual is available for download following this link.